-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點總結如下：我們將MPWR的12個月目標股價從1500美元上調至1600美元，市盈率約為2027年每股收益的58倍，高於同行，以反映我們對該公司強勁增長的預期。在MPWR發布了優於預期的第一季和第二季業績指引後，我們將2026年每股收益預期上調至24.66美元（22.40美元），2027年每股收益預期上調至27.54美元（26.68美元）。 MPWR的優異表現得益於其強大的執行力和多元化的市場策略，尤其是在通訊和企業數據領域，其成長勢頭強勁。 MPWR將今年企業資料領域的成長預期從50%的下限上調至85%，顯示其對人工智慧和伺服器市場前景更加清晰。該公司還宣布計劃將其製造能力從40億美元擴大至60億美元，以支持未來的成長，我們預計這將推動未來兩到三年的業績上漲。通訊業務板塊表現亮眼，環比成長33%，這主要得益於光模組和交換器電源解決方案的強勁銷售。儘管我們對該板塊前景持樂觀態度，但我們認為其過高的估值已經未能充分反映這一增長。
Related Articles
Asia
National Australia Bank Posts Fiscal H1 Cash EPS of AU$0.861, Net Operating Income of AU$10.87 Billion
$ASX:NAB
Asia
Air New Zealand Group Capacity Rises in March
Air New Zealand (ASX:AIZ, NZE:AIR) group capacity rose 4.1% year on year in March, according to a Monday filing with the Australian and New Zealand bourses.Long-haul available seat kilometers (ASKs) rose 2.5%, while domestic ASKs increased by 3.4%, per the filing.Short-haul international ASKs rose 7.6% year on year, supported by the addition of two new A321 aircraft.Group year-to-date underlying revenue per available seat kilometer rose 2.7% from the prior year.The airline carried 1.6 million passengers in March, about the same as the previous year, while the passenger load factor rose to nearly 86%, up from around 83%, the filing added.
$ASX:AIZ$NZE:AIR
Asia
a2 Milk Co. Recalls US Infant Formula Batches After Toxin Detection
a2 Milk Co. (ASX:A2M, NZE:ATM) started a voluntary recall on May 1 of three batches of its a2 Platinum USA infant milk formula, following the detection of cereulide in product manufactured by Synlait Milk (ASX:SM1, NZE:SML), according to separate Monday filings with the Australian and New Zealand bourses.The product was sold only in the US via online platforms and select retailers and had already been discontinued before the recall, while all a2 Platinum products sold outside the US remain unaffected, per the filing.No illnesses have been reported, and any symptoms are typically mild and short-lived, a2 Milk said, adding that it is working with the US Food and Drug Administration and has provided guidance to US consumers who may have purchased the product.The recall reflects updated guidance from New Zealand authorities on managing cereulide risks, a2 Milk said.The companies said they do not expect the recall to impact their financial results.
$ASX:A2M$ASX:SM1$NZE:ATM$NZE:SML